Disparities in Genetic Services and Privacy Webinar Evaluation and Quiz

Please complete this survey/quiz if you viewed a recording of the webinar in order to obtain CEU credit. A score of 80% or higher is required for CEUs. 

Question Title

* 1. First Name

Question Title

* 2. Last Name

Question Title

* 3. Email Address (please use the email address you used to register for the webinar)

Question Title

* 4. Please enter your NSGC User ID (required only if you will be claiming CEUs)

Question Title

* 5. Overall, I thought the webinar was:

Question Title

* 6. Please rate the teaching effectiveness/expertise of Marci Schwartz, MS, LCGC.

Question Title

* 7. The webinar met its objective:  Illustrate examples of roles of genetic counselors in precision medicine and return of results - experiences of an integrated health system.

Question Title

* 8. The webinar met its objective:  Identify patient-care considerations in the setting of genomic screening.

Question Title

* 9. The webinar met its objective: Relate roles of genetic counselors to address challenges related to the return of results experiences for patients and clinicians.

Question Title

* 10. The webinar met its objective: Discuss ways in which genetic counselors impact the field of precision medicine

Question Title

* 11. The content was presented without bias of any commercial product or drug.

Question Title

* 12. Please rate the relevance of the webinar to your work/study

Question Title

* 13. The information presented during the webinar will change the way I practice:

Question Title

* 14. How are most patients at Geisinger consented for genomic screening through the MyCode Community Health Initiative?

Question Title

* 15. Which of the following is a role that research Genetic Counselors at Geisinger do not currently serve in?

Question Title

* 16. Which common genetic finding that is not on the ACMG 59 list is regularly disclosed to MyCode patient-participants?

Question Title

* 17. Which of the following concepts is the most relevant for a patient to understand after they receive a positive result as a secondary finding?

Question Title

* 18. Which of the following is not considered a Tier 1 Condition for the Application of Genomics to Public Health by the Centers for Disease Control and Prevention (CDC)?

Question Title

* 19. Please provide us with any other feedback related to this webinar and future activities:

T